Method of conservative treatment of endometrial polyps
RU2745687C1
Method for treating endometriosis with pain syndrome and pharmaceutical composition for its implementation
RU2738658C1
MEDICINAL AGENT IN FORM OF COMPLEX OF 3,3'-DIINDOLYLMETHANE AND β-CYCLODEXTRIN, METHOD FOR PREPARING THEREOF AND METHOD OF TREATING CERVICAL NEOPLASIA USING THEREOF
RU2740377C1
Method of treating endometriosis and accompanying adhesive process based on 3,3'-diindolylmethane in combination with b-cyclodextrin
RU2733045C1
Method of reproductive function restoration in women with multiple unsuccessful extracorporeal fertilization attempts
RU2708668C1
Method for drug prevention of breast cancer
RU2701525C1
Method of combined therapy of cervical dysplasia associated with human papilloma viruses
RU2665974C1
Inhalation pharmaceutical form of diindolylmethane for treating diseases of upper respiratory passages
RU2655524C1
Natural virucidal agent and virucidal preparation on its basis (options)
RU2601893C1
Drug preparation based on indole-3-carbinol with increased epigenetic activity
RU2537025C1
Diindolylmethane drug preparation and using it for treating influenza and respiratory viral infections
RU2514103C1
Pharmaceutical composition for treating local manifestations of herpex simplex infections and for preventing influenza and acute respiratory viral infections
RU2494733C1
Pharmaceutical composition of phytonutrients having high bioavailability and possessing anti-cancer activity, and method for preparing it (versions)
RU2419426C1
Diindolylmethane (dim)-based medication with increased bioaccessebility and its application in treatment of human hyperplastic and inflammatory diseases
RU2409363C1
Pharmaceutical compositions for peroral delivery of diindolylmethane (dim) and methods for application of these compositions
RU2406497C1
Pharmaceutical composition for adenomyosis treatment and prevention
RU2377305C1
Mucosal vaccine for immune therapy of diseases caused by human papilloma viruses, and related therapy (versions)
RU2395281C2
Pharmaceutical composition for treatment of dysplastic processes of cervix
RU2360926C1
HYBRID PROTEIN CFP10-ESAT6, INDUCING REACTION OF HYPERSENSITIVITY OF DELAYED TYPE WITH RESPECT TO M.Tuberculosis, CODING IT CHIMERIC NUCLEIC ACID AND RECOMBINANT PLASMID EXPRESSION VECTOR, CONTAINING IT, METHOD OF OBTAINING HYBRID PROTEIN AND BASED ON IT DOSED MEDICINAL FORM FOR INTRACUTANEOUS INJECTION
CA2539562A1
Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity
